Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited)

v3.19.3
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Common Stock
Additional Paid-in Capital
Treasury Stock
Accumulated Deficit
Total
Balances at beginning (in shares) at Mar. 31, 2018 500,000 1,160,240 2,318,012 23,068,280        
Balances at beginning at Mar. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 23,100 $ 16,740,400 $ (3,968,100) $ (156,543,800) $ 6,916,600
Proceeds from sale of common stock and warrants for cash in private placement offerings (in shares)       40,000        
Proceeds from sale of common stock and warrants for cash in private placement offerings         50,000     50,000
Proceeds from exercise of warrants (in shares)       5,000        
Proceeds from exercise of warrants         7,500     7,500
Accrued dividends on Series B Preferred stock         (273,500)     (273,500)
Stock-based compensation expense         612,600     612,600
Fair value of common stock issued for services (in shares)       100,000        
Fair value of common stock issued for services       $ 100 122,900     123,000
Net loss             (4,214,500) (4,214,500)
Balances at end (in shares) at Jun. 30, 2018 500,000 1,160,240 2,318,012 23,213,280        
Balances at end at Jun. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 23,200 167,920,900 (3,968,100) (160,758,300) 3,221,700
Balances at beginning (in shares) at Mar. 31, 2018 500,000 1,160,240 2,318,012 23,068,280        
Balances at beginning at Mar. 31, 2018 $ 500 $ 1,200 $ 2,300 $ 23,100 16,740,400 (3,968,100) (156,543,800) 6,916,600
Proceeds from exercise of warrants               7,500
Balances at end (in shares) at Sep. 30, 2018 500,000 1,160,240 2,318,012 28,676,715        
Balances at end at Sep. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 28,700 176,117,900 (3,968,100) (168,193,300) 3,989,200
Balances at beginning (in shares) at Jun. 30, 2018 500,000 1,160,240 2,318,012 23,213,280        
Balances at beginning at Jun. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 23,200 167,920,900 (3,968,100) (160,758,300) 3,221,700
Proceeds from sale of common stock and warrants for cash in private placement offerings (in shares)       3,783,000        
Proceeds from sale of common stock and warrants for cash in private placement offerings       $ 3,800 4,725,000     4,728,800
Accrued dividends on Series B Preferred stock         (283,600)     (283,600)
Stock-based compensation expense         1,172,400     1,172,400
Fair value of common stock issued for PH94B license and option (in shares)       1,630,435        
Fair value of common stock issued for PH94B license and option       $ 1,600 2,248,400     2,250,000
Fair value of common stock issued for services (in shares)       50,000        
Fair value of common stock issued for services       $ 100 334,800     334,900
Net loss             (7,435,000) (7,435,000)
Balances at end (in shares) at Sep. 30, 2018 500,000 1,160,240 2,318,012 28,676,715        
Balances at end at Sep. 30, 2018 $ 500 $ 1,200 $ 2,300 $ 28,700 176,117,900 (3,968,100) (168,193,300) 3,989,200
Balances at beginning (in shares) at Mar. 31, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at beginning at Mar. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,129,900 (3,968,100) (181,133,400) 7,075,200
Accrued dividends on Series B Preferred stock         (302,500)     (302,500)
Stock-based compensation expense         1,063,000     1,063,000
Net loss             (6,209,900) (6,209,900)
Balances at end (in shares) at Jun. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at end at Jun. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,890,400 (3,968,100) (187,343,300) 1,625,800
Balances at beginning (in shares) at Mar. 31, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at beginning at Mar. 31, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,129,900 (3,968,100) (181,133,400) 7,075,200
Proceeds from exercise of warrants               0
Balances at end (in shares) at Sep. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at end at Sep. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,970,100 (3,968,100) (192,679,200) (3,630,400)
Balances at beginning (in shares) at Jun. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at beginning at Jun. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 192,890,400 (3,968,100) (187,343,300) 1,625,800
Accrued dividends on Series B Preferred stock         (313,800)     (313,800)
Stock-based compensation expense         393,500     393,500
Net loss             (5,335,900) (5,335,900)
Balances at end (in shares) at Sep. 30, 2019 500,000 1,160,240 2,318,012 42,758,630        
Balances at end at Sep. 30, 2019 $ 500 $ 1,200 $ 2,300 $ 42,800 $ 192,970,100 $ (3,968,100) $ (192,679,200) $ (3,630,400)